Carregant...
Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
The so-called “biologicals” (monoclonal antibodies to various inflammatory targets like tumor necrosis factor or integrins) have revolutionized the treatment of inflammatory bowel diseases. In ulcerative colitis, they have an established role in inducing remission in steroid-refractory disease and,...
Guardat en:
| Publicat a: | F1000Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
F1000 Research Limited
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081982/ https://ncbi.nlm.nih.gov/pubmed/30135722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.15159.1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|